The role of α-blockers in the management of prostate cancer

Author： Tahmatzopoulos Anastasios   Rowland Randall G   Kyprianou Natasha  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.6, 2004-06, pp. : 1279-1285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefits of long-term α-blockers + 5-α-reductase inhibitors

By  

Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

β-blockers: a new role in cancer chemotherapy?

By Nagaraja Archana S   Sadaoui Nouara C   Lutgendorf Susan K   Ramondetta Lois M   Sood Anil K  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1359-1363

Informa Healthcare

Access to resources Recommend Favorite

Patients receiving α-blockers should inform their ophthalmologist before undergoing eye surgery

By  

Reactions Weekly, Vol. 1, Iss. 1257, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 5, Iss. 5, 2005-08 ,pp. : 307-323

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Imaging in Prostate Cancer: A Review

By Jeschke S.   Schweigreiter E.   Janetschek G.  

Imaging Decisions MRI, Vol. 13, Iss. 3-4, 2009-0 ,pp. : 68-87

Blackwell Publishing

Access to resources Recommend Favorite